Burden of influenza A (H1N1)pdm09 infection among tuberculosis patients: a prospective cohort study
Background Influenza and tuberculosis both cause significant morbidity and mortality worldwide. Therefore, this study aimed to estimate the burden of influenza A (H1N1)pdm09 virus infection among human tuberculosis patients and the general population. Methods A prospective cohort study was conducted among a cohort group (TB positive patients) as exposed and a comparison group (general population) as non-exposed. A total of 304 participants were recruited in both groups and followed for a period of 12 weeks. Of the 304 concurrently enrolled individuals, 152 were TB-positive patients (cohort group) and 152 were from the general population (comparison group).To calculate the sample size, the power of study was kept at 80% for detecting a difference at 5% alpha level assuming the 25% prevalence of respiratory viruses in cohort group compared to 12.5% in general population. An oropharyngeal swab was taken from a participant with symptoms of influenza-like illness (ILI). Samples were tested by conventional reverse transcription polymerase chain reaction (RT-PCR) for the detection of influenza A (H1N1)pdm09. All statistical analyses were conducted using R software. Results A total of 95 participants developed influenza-like illness (ILI) symptoms. Among these, 64 tested positive for influenza A(H1N1)pdm09, of which 39 were from the exposed group and 25 were from the non-exposed group. During the 12-week period of follow-up, the influenza A (H1N1)pdm09 incidence rate was 20 per 1000 people. The risk of testing positive for influenza A (H1N1)pdm09 was 1.66 times higher in the exposed group compared to the non-exposed group. The cumulative incidence indicated that 25% of the TB cohort and 16% of the comparison group were at risk of getting influenza A (H1N1)pdm09 during the 12 weeks of follow-up. Conclusion Participants from the TB cohort had a higher incidence of influenza A (H1N1)pdm09 than the general population suggesting that they should be prioritized for influenza vaccination..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
---|---|
Enthalten in: |
BMC infectious diseases - 23(2023), 1 vom: 10. Aug. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Umbreen, Gulshan [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Cohort studies |
---|
Anmerkungen: |
© The Author(s) 2023 |
---|
doi: |
10.1186/s12879-023-08441-3 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR052701034 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR052701034 | ||
003 | DE-627 | ||
005 | 20231119064802.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230811s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s12879-023-08441-3 |2 doi | |
035 | |a (DE-627)SPR052701034 | ||
035 | |a (SPR)s12879-023-08441-3-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Umbreen, Gulshan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Burden of influenza A (H1N1)pdm09 infection among tuberculosis patients: a prospective cohort study |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © The Author(s) 2023 | ||
520 | |a Background Influenza and tuberculosis both cause significant morbidity and mortality worldwide. Therefore, this study aimed to estimate the burden of influenza A (H1N1)pdm09 virus infection among human tuberculosis patients and the general population. Methods A prospective cohort study was conducted among a cohort group (TB positive patients) as exposed and a comparison group (general population) as non-exposed. A total of 304 participants were recruited in both groups and followed for a period of 12 weeks. Of the 304 concurrently enrolled individuals, 152 were TB-positive patients (cohort group) and 152 were from the general population (comparison group).To calculate the sample size, the power of study was kept at 80% for detecting a difference at 5% alpha level assuming the 25% prevalence of respiratory viruses in cohort group compared to 12.5% in general population. An oropharyngeal swab was taken from a participant with symptoms of influenza-like illness (ILI). Samples were tested by conventional reverse transcription polymerase chain reaction (RT-PCR) for the detection of influenza A (H1N1)pdm09. All statistical analyses were conducted using R software. Results A total of 95 participants developed influenza-like illness (ILI) symptoms. Among these, 64 tested positive for influenza A(H1N1)pdm09, of which 39 were from the exposed group and 25 were from the non-exposed group. During the 12-week period of follow-up, the influenza A (H1N1)pdm09 incidence rate was 20 per 1000 people. The risk of testing positive for influenza A (H1N1)pdm09 was 1.66 times higher in the exposed group compared to the non-exposed group. The cumulative incidence indicated that 25% of the TB cohort and 16% of the comparison group were at risk of getting influenza A (H1N1)pdm09 during the 12 weeks of follow-up. Conclusion Participants from the TB cohort had a higher incidence of influenza A (H1N1)pdm09 than the general population suggesting that they should be prioritized for influenza vaccination. | ||
650 | 4 | |a Influenza |7 (dpeaa)DE-He213 | |
650 | 4 | |a Viruses |7 (dpeaa)DE-He213 | |
650 | 4 | |a Tuberculosis |7 (dpeaa)DE-He213 | |
650 | 4 | |a Humans |7 (dpeaa)DE-He213 | |
650 | 4 | |a Incidence |7 (dpeaa)DE-He213 | |
650 | 4 | |a Prospective studies |7 (dpeaa)DE-He213 | |
650 | 4 | |a Cohort studies |7 (dpeaa)DE-He213 | |
700 | 1 | |a Rehman, Abdul |4 aut | |
700 | 1 | |a Avais, Muhammad |4 aut | |
700 | 1 | |a Jabeen, Chanda |4 aut | |
700 | 1 | |a Sadiq, Shakera |4 aut | |
700 | 1 | |a Maqsood, Rubab |4 aut | |
700 | 1 | |a Rashid, Hamad Bin |4 aut | |
700 | 1 | |a Afzal, Saira |4 aut | |
700 | 1 | |a Chaudhry, Mamoona |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMC infectious diseases |d London : BioMed Central, 2001 |g 23(2023), 1 vom: 10. Aug. |w (DE-627)SPR027459152 |w (DE-600)2041550-3 |x 1471-2334 |7 nnns |
773 | 1 | 8 | |g volume:23 |g year:2023 |g number:1 |g day:10 |g month:08 |
856 | 4 | 0 | |u https://dx.doi.org/10.1186/s12879-023-08441-3 |z kostenfrei |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
951 | |a AR | ||
952 | |d 23 |j 2023 |e 1 |b 10 |c 08 |